Search Results - "Haslerud, Torjan Magne"
-
1
VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
Published in Case reports in hematology (25-02-2023)“…VEXAS syndrome stands for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. The syndrome is a combined hematological and rheumatological…”
Get full text
Journal Article -
2
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis
Published in Current oncology (Toronto) (23-03-2022)“…Basal cell carcinoma (BCC) is the most common cancer in Caucasians. It is slow growing and rarely metastasizes. If left untreated over time, invasive growth…”
Get full text
Journal Article -
3
Kidney Failure and Abdominal Discomfort as Initial Signs of Extramedullary Acute Myelogenous Leukemia
Published in Clinics and practice (22-07-2021)“…Although rare, acute myelogenous leukemia (AML) can include extramedullary manifestations, sometimes presenting as a solid tumor called a myeloid sarcoma…”
Get full text
Journal Article -
4
Solid lærebok om nukleærmedisin
Published in Tidsskrift for den Norske Lægeforening (13-03-2023)Get full text
Journal Article -
5
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
Published in British journal of cancer (07-12-2023)“…Background The optimal treatment for metastatic high-grade gastroenteropancreatic (GEP) neuroendocrine neoplasms when Ki-67 ≤55% is unknown. A prospective…”
Get full text
Journal Article -
6
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
Published in Cancer Immunology, Immunotherapy (01-07-2023)“…Metastatic castration-resistant prostate cancer (mCRPC) is an immunologically cold disease with dismal outcomes. Cryoablation destroys cancer tissue, releases…”
Get full text
Journal Article -
7
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis
Published in Current oncology (Toronto, Ont.) (23-03-2022)Get full text
Report